The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Solid lipid nanoparticles as drug delivery systems
Abstract
For a decade, trials have been made to utilize solid lipid nanoparticles (SLNs) as alternative drug delivery systems to colloidal drug delivery systems such as lipid emulsions, liposomes, and polymeric nanoparticles. Various lipid matrices, surfactants, and other excipients used in formulation, preparation methods, sterilization and lyophilization of SLNs are discussed in this article. Entrapment efficiency of drug carrier and its effect on physical parameters, drug release, and release mechanisms of various compositions are reviewed and discussed. Important points in characterization and stability of SLNs are outlined. Various in vitro studies carried out by different research groups are mentioned in addition to in vivo evaluation. Exploitation potential of SLNs to administer by various routes of administration are covered. Passive and active drug targeting using SLNs are presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism
zur Mühlen, A., Schwarz, C., & Mehnert, W. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00150-1 · Cited by 945
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres
Gref, R., Domb, A., Quellec, P., Blunk, T., Müller, R. H., Verbavatz, J. M., & Langer, R. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00026-4 · Cited by 820
Freitas, C., & Müller, R. H. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00092-1 · Cited by 687
Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System
Bazile, D., Prud'homme, C., Bassoullet, M., Marlard, M., Spenlehauer, G., & Veillard, M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840420 · Cited by 635
Jenning, V., Thünemann, A. F., & Gohla, S. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00378-1 · Cited by 593
Schwarz, C., Mehnert, W., Lucks, J. S., & Müller, R. H. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90047-7 · Cited by 574
Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles
Venkateswarlu, V., & Manjunath, K. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.005 · Cited by 558
Self-citationDesign of Folic Acid‐Conjugated Nanoparticles for Drug Targeting
Stella, B., Arpicco, S., Peracchia, M. T., Desmaële, D., Hoebeke, J., Renoir, M., D'Angelo, J., Cattel, L., & Couvreur, P. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11<1452::aid-jps8>3.0.co;2-p · Cited by 553
Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties
Jenning, V., Schäfer-Korting, M., & Gohla, S. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00223-0 · Cited by 545
Westesen, K., Bunjes, H., & Koch, M. H. J. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00046-1 · Cited by 536
Jenning, V., Gysler, A., Schäfer-Korting, M., & Gohla, S. H. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00075-2 · Cited by 528
Freitas, C., & Müller, R. H. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00074-5 · Cited by 483
Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., & Yang, C. Z. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00007-3 · Cited by 476
Müller, R. H., Mehnert, W., Lucks, J. S., Schwarz, C., Mühlen, A. Z., Meyhers, H., de Freitas, C. F., & Rühl, D. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 455
Schubert, M. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00130-3 · Cited by 454
Preparation of solid lipid nanoparticles by a solvent emulsification–diffusion technique
Trotta, M., Debernardi, F., & Caputo, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00135-2 · Cited by 439
Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration
Wissing, S. A., & Müller, R. H. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00056-1 · Cited by 402
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin
Cavalli, R., Gasco, M. R., Chetoni, P., Burgalassi, S., & Saettone, M. F. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00080-7 · Cited by 389
Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration
Yang, S., Zhu, J., Lu, Y., Liang, B., & Yang, C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018888927852 · Cited by 324
Fundarò, A., Cavalli, R., Bargoni, A., Vighetto, D., Zara, G. P., & Gasco, M. R. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0695 · Cited by 317
Encapsulation of retinoids in solid lipid nanoparticles (SLN)
Volkhard Jenning, S. H. G. (2001) · Journal of Microencapsulation · doi:10.1080/02652040010000361 · Cited by 315
Hu, F. Q., Yuan, H., Zhang, H. H., & Fang, M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00081-9 · Cited by 284
Spray-drying of solid lipid nanoparticles (SLNTM)
Freitas, C., & Müller, R. H. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00172-0 · Cited by 282
Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles
Cavalli, R. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04822-3 · Cited by 273
Cytotoxicity of Solid Lipid Nanoparticles as a Function of the Lipid Matrix and the Surfactant
Müller, R. H., Rühl, D., Runge, S., Schulze-Forster, K., & Mehnert, W. (1997) · Pharmaceutical Research · doi:10.1023/a:1012043315093 · Cited by 265
Brain uptake of thiamine-coated nanoparticles
Lockman, P. R., Oyewumi, M. O., Koziara, J. M., Roder, K. E., Mumper, R. J., & Allen, D. D. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.08.006 · Cited by 259
Müller, R. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04539-5 · Cited by 242
SCHWARZ, C. (1999) · Journal of Microencapsulation · doi:10.1080/026520499289185 · Cited by 235
Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN)
Schwarz, C., & Mehnert, W. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00222-6 · Cited by 234
Müller, R., Maaben, S., Weyhers, H., & Mehnert, W. (1996) · Journal of Drug Targeting · doi:10.3109/10611869609015973 · Cited by 222
Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles
Siekmann, B., & Westesen, K. (1994) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/0927-7765(94)80063-4 · Cited by 217
A. Dingler, R. P. B. (1999) · Journal of Microencapsulation · doi:10.1080/026520499288690 · Cited by 217
Sjöström, B., & Bergenståhl, B. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90303-j · Cited by 215
Enzymatic degradation of SLN—effect of surfactant and surfactant mixtures
Olbrich, C., & Müller, R. H. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00404-9 · Cited by 208
Zara, G. P., Cavalli, R., Bargoni, A., Fundarò, A., Vighetto, D., & Gasco, M. R. (2002) · Journal of Drug Targeting · doi:10.1080/10611860290031868 · Cited by 207
Westesen, K., Siekmann, B., & Koch, M. H. J. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90177-h · Cited by 206
Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles
Westesen, K., & Siekmann, B. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)04890-4 · Cited by 198
Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters
Almeida, A. J., Runge, S., & Müller, R. H. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)04885-0 · Cited by 193
Jores, K., Mehnert, W., & Mäder, K. (2003) · Pharmaceutical Research · doi:10.1023/a:1025065418309 · Cited by 185
Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA
Olbrich, C., Bakowsky, U., Lehr, C.-M., Müller, R. H., & Kneuer, C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00506-5 · Cited by 181
Miglietta, A., Cavalli, R., Bocca, C., Gabriel, L., & Rosa Gasco, M. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00562-7 · Cited by 180
Wang, J.-X., Sun, X., & Zhang, Z.-R. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00083-8 · Cited by 179
Olbrich, C., Gessner, A., Kayser, O., & Müller, R. H. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000001832 · Cited by 175
Solid lipid nanoparticles (SLN) for controlled drug delivery
Müller, R. H., Freitas, C., zur Mühlen, A., & Mehnert, W. (1996) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)86243-4 · Cited by 174
Comparison of wax and glyceride solid lipid nanoparticles (SLN®)
Jenning, V., & Gohla, S. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00426-3 · Cited by 168
Preparation and characterization of solid lipid nanoparticles containing peptide
Hu, F. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.12.016 · Cited by 168
Biodegradation of solid lipid nanoparticles as a function of lipase incubation time
Müller, R. H., Rühl, D., & Runge, S. (1996) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04731-x · Cited by 155
Zimmermann, E., & Müller, R. H. (2001) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00167-9 · Cited by 151
Moghimi, S. M., Hawley, A. E., Christy, N. M., Gray, T. B., Illum, L., & Davis, S. S. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00351-3 · Cited by 150
Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix?
Westesen, K., & Bunjes, H. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00347-8 · Cited by 149
Schöler, N., Hahn, H. H., Müller, R. H., & Liesenfeld, O. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00882-1 · Cited by 149
Zara, G. P., Bargoni, A., Cavalli, R., Fundaro', A., Vighetto, D., & Gasco, M. R. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10129 · Cited by 143
Physical Chemical Considerations of Lipid-Based Oral Drug Delivery-Solid Lipid Nanoparticles
Bummer, P. M. (2004) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v21.i1.10 · Cited by 137
Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin
Cavalli, R., Bargoni, A., Podio, V., Muntoni, E., Zara, G. P., & Gasco, M. R. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10368 · Cited by 133
Cavalli, R. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00066-6 · Cited by 125
Solid lipid nanoparticles (SLN)--a novel carrier for UV blockers.
Wissing, S. A., & Müller, R. H. (2001) · PubMed · Cited by 124
Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions
Siekmann, B., & Westesen, K. (1996) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 123
Influence of different parameters on reconstitution of lyophilized SLN
Zimmermann, E., Müller, R. H., & Mäder, K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00424-x · Cited by 118
Studies on the cyclosporin A loaded stearic acid nanoparticles
Zhang, Q., Yie, G., Li, Y., Yang, Q., & NAGAI, T. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00361-6 · Cited by 114
Sznitowska, M., Gajewska, M., Janicki, S., Radwanska, A., & Lukowski, G. (2001) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00157-6 · Cited by 113
Heiati, H., TAWASHI, R., & Phillips, N. C. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006847 · Cited by 113
Müller, R. H., & Wallis, K. H. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90304-x · Cited by 106
Müller, R. H., Maassen, S., Schwarz, C., & Mehnert, W. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)01653-2 · Cited by 100
Freitas, C., & Müller, R. H. (1999) · Journal of Microencapsulation · doi:10.1080/026520499289310 · Cited by 94
Investigation on the viscoelastic properties of lipid based colloidal drug carriers
Lippacher, A., Müller, R. H., & Mäder, K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00428-7 · Cited by 92
LIPID-BASED VEHICLE FOR ORAL DRUG DELIVERY
Stuchlík, M., & Žák, S. (2001) · Biomedical Papers · doi:10.5507/bp.2001.008 · Cited by 92
Scaling up feasibility of the production of solid lipid nanoparticles (SLN).
Gohla, S., & Dingler, A. (2001) · PubMed · Cited by 78
Formulation andin vitro-in vivoevaluation of piribedil solid lipid micro- and nanoparticles
Demirel, Y. Y. M. (2001) · Journal of Microencapsulation · doi:10.1080/02652040010018119 · Cited by 74
Structural Characterization of Q10-Loaded Solid Lipid Nanoparticles by NMR Spectroscopy
Wissing, S. A., Müller, R. H., Manthei, L., & Mayer, C. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000019291.36636.c1 · Cited by 73
Moghimi, S. M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00024-2 · Cited by 72
Crystallographic investigation of cetylpalmitate solid lipid nanoparticles
Lukowski, G., Kasbohm, J., Pflegel, P., et al. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00421-4 · Cited by 61
Influence of surfactants on the physical stability of solid lipid nanoparticle (SLN) formulations.
Üner, M., Wissing, S. A., Yener, G., & Müller, R. H. (2004) · PubMed · Cited by 55
Long-Term Studies of Microencapsulated and Adsorbed Influenza Vaccine Nanoparticles
Kreuterx, J., & Liehl, E. (1981) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600700406 · Cited by 49
Yu, B., Sun, X., & Zhang, Z. (2003) · Archives of Pharmacal Research · doi:10.1007/bf02994764 · Cited by 47
Podio, V., Zara, G. P., Carazzone, M., et al. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001774976 · Cited by 38
Schöler, N., Zimmermann, E., Katzfey, U., et al. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00430-5 · Cited by 35
Schöler, E. Z. N. (2000) · Journal of Microencapsulation · doi:10.1080/026520400417685 · Cited by 24
Cited by
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application
Naseri, N., Valizadeh, H., & Zakeri-Milani, P. (2015) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2015.043 · Cited by 1,116
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
Das, S., & Chaudhury, A. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-010-9563-0 · Cited by 838
Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems
Mishra, V., Bansal, K. K., Verma, A., Yadav, N., Thakur, S., Sudhakar, K., & Rosenholm, J. M. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040191 · Cited by 669
Ganesan, P., & Narayanasamy, D. (2017) · Sustainable Chemistry and Pharmacy · doi:10.1016/j.scp.2017.07.002 · Cited by 434
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives
Edis, Z., Wang, J., Waqas, M. K., Ijaz, M., & Ijaz, M. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s289443 · Cited by 390
Metadata
- Authors
- Manjunath, K., Reddy, J. S., & Venkateswarlu, V.
- Venue
- Methods and Findings in Experimental and Clinical Pharmacology
- Publisher
- Portico
- Published
- 2005
- Volume
- 27
- Issue
- 2
- Pages
- 127
- ISSN
- 0379-0355 (ISSN-L)
- 2013-0155
- OpenAlex
- W1964896591
- Cited by
- 306
- References
- 80
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.